Financial Results : Sulaiman Al Habib profit rises 4% to SAR 2.4B in 2025; Q4 at SAR 651.2M

Sulaiman Al Habib profit rises 4% to SAR 2.4B in 2025; Q4 at SAR 651.2M

15/02/2026 Argaam Exclusive

View other reports

Dr. Sulaiman Al Habib Medical Services Group reported a net profit of SAR 2.4 billion for 2025, an increase of 4% from SAR 2.3 billion in the year-earlier period.



Financials (M)

Item 2024 2025 Change‬
Revenues 11,200.43 13,706.90 22.4 %
Gross Income 3,744.26 4,207.01 12.4 %
Operating Income 2,356.26 2,618.98 11.1 %
Net Income 2,315.29 2,401.47 3.7 %
Average Shares 350.00 350.00 -
Earnings Per Share before unusual items (Riyals) 6.49 6.86 5.8 %
EPS (Riyal) 6.62 6.86 3.7 %

Revenues rose 22.38% year-on-year (YoY) during 2025 to SAR 13.7 billion, driven by growth in hospitals and pharmacies segments as patient volumes and occupancy rates improved.

 

Newly commissioned hospitals are currently in the ramp-up phase, and revenue contribution is expected to increase progressively as they move toward optimal utilization, the group said.

 

Meanwhile, EBITDA increased by 17.86% to SAR 3.5 billion from SAR 2.97 billion in 2024. EBITDA margin reached 25.59%.



Current Quarter Comparison (M)

Compared With The
Item Q4 2024 Q4 2025 Change‬
Revenues 3,128.85 3,701.45 18.3 %
Gross Income 996.81 1,062.79 6.6 %
Operating Income 624.13 682.48 9.3 %
Net Income 613.77 651.16 6.1 %
Average Shares 350.00 350.00 -
Earnings Per Share before unusual items (Riyal) 1.63 1.86 14.5 %
EPS (Riyal) 1.75 1.86 6.1 %

Q4 2024 net profit rose 6% to SAR 651.2 million from SAR 613.8 million a year ago.

 

On a sequential basis, net earnings grew 8.1% from SAR 602.28 million in Q3 2025.

 

Total shareholders’ equity, after minority interest, stood at SAR 7.90 billion by Dec. 31, 2025, compared to SAR 7.17 billion a year earlier.

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.